Search PubMed⌕ Search

Biomedical subjects

M Boddi

Publications and source records attributed to M Boddi.

43 records · Page 3Linked to original sources
PubMed1987

Effects of indenolol on blood pressure, lower limb blood flow, adrenergic reflexes, and plasma renin activity.

The antihypertensive effects of indenolol, a new not-cardioselective beta-blocking agent, were evaluated in patients with WHO grades I and II essential hypertension (range 160/95 to 200/115 mm Hg) in a double-blind, placebo-controlled study after acute (12 patients) and 2-week treatment (seven patients). Indenolol (30 to 120 mg) reduced blood pressure in a dose-dependent fashion. Maximum reduction was 26 mm Hg for systolic and 17 mm Hg for diastolic pressure. Hypotensive activity commenced within 10 minutes, peaked in 60 minutes, and persisted for about 7 hours. Lower limb vascular resistance (strain-gauge plethysmography) was significantly lowered, thus suggesting an intrinsic sympathomimetic activity. Heart rate was progressively reduced at 30 and 60 mg without any additional effect at 120 mg. Indenolol did not alter adrenergic reflexes (standing, cold application, and hand-grip) and did not induce any side effect. In conclusion, indenolol possesses an antihypertensive activity associated with reduction of vascular resistance.

Adrenergic beta-Antagonists↗
PubMed1987

Twenty-four-hour heart rate behavior in patients with impaired left ventricular function due to coronary heart disease.

We performed a 24-hour Holter monitoring study on 45 patients affected by coronary artery disease (CAD) with different degrees of left ventricular impairment, and on 15 controls, in order to observe heart rate (HR) changes. According to the ejection fraction (EF) determined by cardiac angiography, CAD patients were divided into 3 groups of 15 each: the first with EF greater than 0.5; the second with EF between 0.35 and 0.5 and the third with EF less than 0.35. Spontaneous HR variation during 24 h did not differ among controls and CAD patients with normal EF values. On the contrary, with the reduction of ventricular function, CAD patients showed increasingly higher values of HR only during the night. Patients with markedly reduced EF values showed higher values of HR than controls even during some hours of the day. During the night EF and HR showed a good linear correlation with the highest r value at 5 a.m. (r = 0.7, p less than 0.001). Present data show that a reduction in left ventricular performance results in an altered 24-hour HR pattern with a reduced HR slowing at night proportional to the extent of left ventricular dysfunction.

Adult↗
PubMed1987

Transcutaneous oximetry in evaluation of the initial peripheral artery disease in diabetics.

This study was performed to evaluate the reliability of transcutaneous oximetry as compared with strain gauge plethysmography and with Doppler in the assessment of the initial peripheral vascular disease in diabetics who are still asymptomatic. Twenty-five diabetics (38 lower extremities) with different degrees of peripheral vascular disease, classified according to Fontaine, were investigated. Ten healthy subjects (16 lower extremities) served as controls. In the first group of patients (still asymptomatic) it was possible to select by transcutaneous oximetry and by plethysmography a subpopulation that presented a significant reduction in the arterial flow of the limbs. Moreover, a significant correlation between data obtained by strain gauge plethysmography and transcutaneous oximetry was found (p less than 0.001), whereas correlation with data from Doppler was lacking.

Adult↗
PubMed1986

Factors influencing platelet aggregation in whole blood.

In order to evaluate the interference of blood cells on platelet aggregation, spontaneous platelet aggregation (SPA), ADP, and collagen-induced platelet aggregation were investigated in whole blood by the impedance method and in platelet-rich plasma (PRP) by densitometric and impedance aggregometers. Stirring of the sample induced a significant decrease of neutrophils (P less than 0.001) but no changes of red blood cell (RBC) and platelet count. After collagen addition, a further decrease of neutrophils was observed, while RBC count was unmodified. The occurrence of SPA was not different in whole blood and in PRP. Platelet number and hematocrit did not affect either spontaneous or collagen-induced aggregation. A significant linear relation (r = -0.60, P less than 0.01) between neutrophil count and collagen whole blood platelet aggregation was found. Collagen- and ADP-induced aggregation were significantly higher and lower, respectively, in whole blood than in PRP using the densitometric method. No differences were observed in SPA and collagen platelet aggregation according to age and sex.

Adult↗
PubMed1985

Pentoxifylline treatment in patients with occlusive peripheral arterial disease. Circulatory changes and effects on prostaglandin synthesis.

Pentoxifylline has recently been reported to stimulate in vitro the synthesis of prostacyclin. However it is not known so far whether the drug is able to stimulate prostacyclin synthesis in man also in vivo. In the present study the effects of pentoxifylline on prostaglandin synthesis and several circulatory parameters were studied in 10 controls and 10 patients with occlusive arterial disease after acute i.v. and medium term oral treatment. Prostacyclin (as 6-keto-PGF1 alpha) and PGE2 plasma concentrations have been measured together with arterial blood flow, peripheral vascular resistance, platelet aggregation and red blood cell deformability. Pentoxifylline was found both in healthy subjects and patients to significantly increase prostacyclin plasma concentration after i.v. treatment. In medium term oral treatment prostacyclin concentration was found to increase only two hours after administration and not 8 hours after. No significant variations in PGE2 plasma concentration were found at any time in both groups. Pentoxifylline significantly enhanced resting and post-ischemic blood flow of the lower limbs and simultaneously decreased peripheral vascular resistance both in healthy subjects and patients. Different grades of delayed platelet aggregation and increased red blood cell deformability were also observed. In conclusion results of the present placebo controlled study show that pentoxifylline increases arterial blood flow in patients with occlusive arterial disease. Moreover pentoxifylline induces a temporary stimulation of prostacyclin synthesis which can be suggested to contribute to the clinical activity of the drug as far as an antithrombotic effect in terms of inhibition of platelet aggregation is concerned.

6-Ketoprostaglandin F1 alpha↗
PubMed1984

[Arrhythmogenic dysplasia of the right ventricle. Description of a case].

A 43 year old man was admitted to our Clinic because of recurrent episodes of palpitation. The electrocardiogram showed incomplete right bundle branch block, frequent ventricular extrasystoles with left bundle branch block morphology and negative T waves in the precordial leads. Two dimensional echocardiography showed marked right ventricular dilatation and right ventricular radionuclide angiography located the enlargment in the infundibulum. Arrhythmogenic right ventricular dysplasia was then suspected. Cardiac angiography excluded the other most common causes of right ventricular dilatation and confirmed the diagnosis. Arrhythmogenic right ventricular dysplasia should thus be regarded as a possible cause of ventricular arrhythmias of unknown etiology.

Adult↗